Neuralink Brain Implants Now in 21 People: From Typing With Thoughts to Restoring Vision
What was once the domain of science fiction is now clinical reality. As of January 28, 2026, Elon Musk's brain-computer interface company Neuralink has successfully implanted its N1 brain chip in 21 human patients across four countries — the United States, Canada, the United Kingdom, and the United Arab Emirates. These patients, most of whom are paralyzed or living with ALS, are now controlling computers, playing video games, and even speaking through AI-cloned voices using nothing but their thoughts.
This article breaks down every major milestone, the technology behind the N1 implant, the patient stories, complications, clinical trials, competitor landscape, and what this means for the future of medicine — including the potential impact on India.
The Timeline: From 1 Patient to 21
| Date | Milestone | Total Patients |
|---|---|---|
| May 2023 | FDA grants Investigational Device Exemption (IDE) for human trials | 0 |
| January 2024 | First human implant — Noland Arbaugh, 29, quadriplegic | 1 |
| Mid-2025 | Five patients implanted, PRIME trial expanding | 5 |
| September 2025 | 12 patients across US trials | 12 |
| Late 2025 | International expansion — UK (GB-PRIME), Canada (CAN-PRIME) | ~15 |
| January 28, 2026 | 21 patients confirmed across US, Canada, UK, UAE | 21 |
The acceleration from 1 to 21 patients in just two years demonstrates that the surgical procedure is becoming standardized and the technology is proving safe enough for regulatory bodies across multiple countries to authorize trials.
Premium Content
You've read all your free articles today. Subscribe to continue reading.
You've used 3 of 3 free articles today.
Subscribe NowAlready subscribed? Sign in




Comments (0)
Be the first to comment!